AeskuLab k.s.

Teplice 415 01

0 studies enrolling now · 4 studies all time

What they study most

Atherosclerosis, Cardiovascular Diseases, Dyslipidemia, Hypertriglyceridemia, Severe Hypertriglyceridemia, Type2 Diabetes

Studies at this site

• A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia — Completed
• CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG) — Running, not enrolling
• A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia — Completed
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early